1v26 Citations

Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer.

J Biol Chem 279 31717-26 (2004)
Related entries: 1ult, 1v25

Cited: 124 times
EuropePMC logo PMID: 15145952

Abstract

Long chain fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of long chain fatty acyl-CoA esters. We report the first crystal structures of long chain fatty acyl-CoA synthetase homodimer (LC-FACS) from Thermus thermophilus HB8 (ttLC-FACS), including complexes with the ATP analogue adenosine 5'-(beta,gamma-imido) triphosphate (AMP-PNP) and myristoyl-AMP. ttLC-FACS is a member of the adenylate forming enzyme superfamily that catalyzes the ATP-dependent acylation of fatty acid in a two-step reaction. The first reaction step was shown to propagate in AMP-PNP complex crystals soaked with myristate solution. Myristoyl-AMP was identified as the intermediate. The AMP-PNP and the myristoyl-AMP complex structures show an identical closed conformation of the small C-terminal domains, whereas the uncomplexed form shows a variety of open conformations. Upon ATP binding, the fatty acid-binding tunnel gated by an aromatic residue opens to the ATP-binding site. The gated fatty acid-binding tunnel appears only to allow one-way movement of the fatty acid during overall catalysis. The protein incorporates a hydrophobic branch from the fatty acid-binding tunnel that is responsible for substrate specificity. Based on these high resolution crystal structures, we propose a unidirectional Bi Uni Uni Bi Ping-Pong mechanism for the two-step acylation by ttLC-FACS.

Reviews - 1v26 mentioned but not cited (1)

Articles - 1v26 mentioned but not cited (8)



Reviews citing this publication (22)

  1. Carnitine transport and fatty acid oxidation. Longo N, Frigeni M, Pasquali M. Biochim Biophys Acta 1863 2422-2435 (2016)
  2. Structure and function of enzymes involved in the biosynthesis of phenylpropanoids. Ferrer JL, Austin MB, Stewart C, Noel JP. Plant Physiol Biochem 46 356-370 (2008)
  3. The origin and evolution of lignin biosynthesis. Weng JK, Chapple C. New Phytol 187 273-285 (2010)
  4. Mammalian long-chain acyl-CoA synthetases. Soupene E, Kuypers FA. Exp Biol Med (Maywood) 233 507-521 (2008)
  5. Acyl-CoA metabolism and partitioning. Grevengoed TJ, Klett EL, Coleman RA. Annu Rev Nutr 34 1-30 (2014)
  6. Acyl-CoA synthesis, lipid metabolism and lipotoxicity. Li LO, Klett EL, Coleman RA. Biochim Biophys Acta 1801 246-251 (2010)
  7. Yeast acyl-CoA synthetases at the crossroads of fatty acid metabolism and regulation. Black PN, DiRusso CC. Biochim Biophys Acta 1771 286-298 (2007)
  8. Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms. Yamashita A, Hayashi Y, Nemoto-Sasaki Y, Ito M, Oka S, Tanikawa T, Waku K, Sugiura T. Prog Lipid Res 53 18-81 (2014)
  9. The dimycocerosate ester polyketide virulence factors of mycobacteria. Onwueme KC, Vos CJ, Zurita J, Ferreras JA, Quadri LE. Prog Lipid Res 44 259-302 (2005)
  10. The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids. Green JT, Orr SK, Bazinet RP. J Lipid Res 49 939-944 (2008)
  11. Bacterial long chain fatty acid transport: gateway to a fatty acid-responsive signaling system. Dirusso CC, Black PN. J Biol Chem 279 49563-49566 (2004)
  12. Exogenous fatty acid metabolism in bacteria. Yao J, Rock CO. Biochimie 141 30-39 (2017)
  13. Enzymes without borders: mobilizing substrates, delivering products. Forneris F, Mattevi A. Science 321 213-216 (2008)
  14. Fatty acid transport proteins and insulin resistance. Fisher RM, Gertow K. Curr Opin Lipidol 16 173-178 (2005)
  15. Small molecule inhibition of microbial natural product biosynthesis-an emerging antibiotic strategy. Cisar JS, Tan DS. Chem Soc Rev 37 1320-1329 (2008)
  16. O-GlcNAcylation: a bridge between glucose and cell differentiation. Sun C, Shang J, Yao Y, Yin X, Liu M, Liu H, Zhou Y. J Cell Mol Med 20 769-781 (2016)
  17. Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors. Lux MC, Standke LC, Tan DS. J Antibiot (Tokyo) 72 325-349 (2019)
  18. Membrane lipid alterations in hemoglobinopathies. Kuypers FA. Hematology Am Soc Hematol Educ Program 68-73 (2007)
  19. Acyl-CoA synthetases as regulators of brain phospholipid acyl-chain diversity. Fernandez RF, Ellis JM. Prostaglandins Leukot Essent Fatty Acids 161 102175 (2020)
  20. Mitochondrial Homeostasis Mediates Lipotoxicity in the Failing Myocardium. Kretzschmar T, Wu JMF, Schulze PC. Int J Mol Sci 22 1498 (2021)
  21. Access and utilization of long chain fatty acyl-CoA by zDHHC protein acyltransferases. Puthenveetil R, Gómez-Navarro N, Banerjee A. Curr Opin Struct Biol 77 102463 (2022)
  22. Fatty acid metabolism and acyl-CoA synthetases in the liver-gut axis. Ma Y, Nenkov M, Chen Y, Press AT, Kaemmerer E, Gassler N. World J Hepatol 13 1512-1533 (2021)

Articles citing this publication (93)